According to a new market research report published by Inkwood Research, the Global DNA Sequencing Market is escalating at a compound annual growth rate of 17.46% between 2019 and 2027.
|
"Browse 43 market Data Tables and 51 Figures spread over 230 Pages, along with an in-depth TOC on Global DNA Sequencing Market Forecast 2019-2027".
 |
| Global DNA Sequencing Market Forecast 2019-2027
REQUEST FREE SAMPLE LINK- https://www.inkwoodresearch.com/reports/dna-sequencing-market/#request-free-sample
Increasing
incidence of cancer cases is a major driver boosting the global DNA Sequencing
market. The cancer studies of the genomic period are witnessing tremendous
growth, pushed by the introduction of next-generation sequencing techniques
with advantages, such as sensitivity and sharp resolution. The
conventional techniques of discovering the genomic foundations of diverse
cancers involved targeted examination of particular variants and genes in a
low-throughput fashion. The majority of cancers are genetically composite and
are better distinct by the creation of signaling pathways rather than a
definite set of mutations. The success of the human genome project encouraged
similar projects looking at the genome in several cancers. That success, along
with the augmented reliability and affordability of sequencing, has led to the
addition of genome science into medical practice, which in turn is driving the
global DNA sequencing market.
Biomarkers
are the essential elements that assist in diagnosing the presence of disease.
The Improvisation of treatment and inhibition of chronic conditions such as diabetes,
cancer and cardiovascular diseases is potentially probable through the
intervention of biomarkers. The clinical relevance of molecular biomarkers and translational
research in the treatment of diseases has been relatively uncertain due to genetic
variability among patients with the same condition. Nevertheless, DNA
sequencing is capable of recognizing a broad spectrum of genetic differences
and enhance the introduction of important biomarkers in medicine and disease
diagnosis. Thus, it can be stated that DNA sequencing has revolutionized the
discovery and identification of different biomarkers.
North America - Dominant Region in the Global
Market
The global market for DNA sequencing is dominated by
the North American region in terms of revenue in the year 2019, and is expected
to continue its lead over the forecasting period. The attributes supplementing
the regional market are various cases of chronic disorders and a rise in the geriatric
population. Also, the prevailing instances of cancer types, including lung,
breast, prostate, bronchus, rectum, colon, melanoma of the skin, leukemia, and
others, are propelling the demand for DNA sequencing in the region.
The global DNA sequencing market is marked by high
competition led by dominant players, such as Illumina, Thermo Fisher
Scientific, and Roche Diagnostics. These companies deploy strategies such as
the launch of novel platforms that are faster, smaller in size, and less
expensive to improve their market presence. The other prominent vendors in the
market are Agilent Technologies, Adaptive Biotechnologies, and WaferGen
Bio-Systems. These companies are also looking for efficient products for fast
and accurate DNA sequencing.
About Inkwood Research
Inkwood Research specializes in
syndicated & customized research reports and consulting services. Market
intelligence studies with relevant fact-based research are customized across
industry verticals such as technology, automotive, chemicals, materials, healthcare,
and energy, with an objective comprehension that acknowledges the business
environments. Our geographical analysis comprises of North & South America,
CEE, CIS, Middle East, Europe, Asia, and Africa.
Contact Us
+1 857-302-4704
Related Report:
|
Comments
Post a Comment